A comprehensive systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai has established a significant association between exposure to per- and polyfluoroalkyl substances and an increased risk of gestational diabetes mellitus, alongside altered markers
A groundbreaking discovery has unveiled a class of small molecules that effectively teach the body to eliminate its own disease-causing components, a development that could rewrite the rules for treating some of the most stubborn medical conditions. An international team of scientists has
With over two decades of research in biopharma, Ivan Kairatov has witnessed the evolution of microbiome science from a niche interest into a central player in our understanding of health. As an expert in R&D and technological innovation, he has a unique perspective on the translational gap—the
The convergence of advanced computational intelligence with molecular biology has fundamentally altered the paradigm of vaccine development, shifting it from a process of slow, empirical discovery to one of rapid, data-driven design. The application of Artificial Intelligence (AI) in this field
The relentless search for an effective treatment for Alzheimer's disease has long been a monumental challenge for modern medicine, often characterized by a slow, costly, and high-failure process of drug discovery. A groundbreaking study now presents a powerful computational framework that promises
In the world of genetic diagnostics, some of the most critical clues are hidden in plain sight, visible only through a microscope. Yet, the human eye, for all its power, can be a subjective tool. Ivan Kairatov, a biopharma expert at the forefront of technological innovation in research and
